Advanced approaches in the comprehensive management of gastroparesis: from etiology to emerging therapies.

IF 1.5 Q3 GASTROENTEROLOGY & HEPATOLOGY Minerva gastroenterology Pub Date : 2025-06-01 Epub Date: 2025-02-27 DOI:10.23736/S2724-5985.24.03804-X
Vishali Moond, Sahib Singh, Umar Hayat, Parth Patel, Archit Garg, Hassam Ali, Douglas G Adler
{"title":"Advanced approaches in the comprehensive management of gastroparesis: from etiology to emerging therapies.","authors":"Vishali Moond, Sahib Singh, Umar Hayat, Parth Patel, Archit Garg, Hassam Ali, Douglas G Adler","doi":"10.23736/S2724-5985.24.03804-X","DOIUrl":null,"url":null,"abstract":"<p><p>Gastroparesis is a chronic gastrointestinal disorder characterized by delayed gastric emptying without mechanical obstruction, leading to symptoms such as nausea, vomiting, and abdominal pain. Despite its significant impact on patient quality of life, effective management remains challenging. Current treatments, such as prokinetic agents and antiemetics, offer symptomatic relief but have limitations, necessitating the exploration of new approaches. We reviewed the most recent literature using PubMed and Medline, focusing on studies that address the etiology, pathophysiology, and management of gastroparesis, including novel pharmacological agents, endoscopic techniques, and lifestyle modifications. Emerging therapies, including gastric peroral endoscopic myotomy and ghrelin agonists, show promise in improving patient outcomes. In this review, we examine these therapeutic advancements and discuss their potential role in the future management of gastroparesis.</p>","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"116-131"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-5985.24.03804-X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gastroparesis is a chronic gastrointestinal disorder characterized by delayed gastric emptying without mechanical obstruction, leading to symptoms such as nausea, vomiting, and abdominal pain. Despite its significant impact on patient quality of life, effective management remains challenging. Current treatments, such as prokinetic agents and antiemetics, offer symptomatic relief but have limitations, necessitating the exploration of new approaches. We reviewed the most recent literature using PubMed and Medline, focusing on studies that address the etiology, pathophysiology, and management of gastroparesis, including novel pharmacological agents, endoscopic techniques, and lifestyle modifications. Emerging therapies, including gastric peroral endoscopic myotomy and ghrelin agonists, show promise in improving patient outcomes. In this review, we examine these therapeutic advancements and discuss their potential role in the future management of gastroparesis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胃轻瘫综合治疗的先进方法:从病因学到新兴疗法。
胃轻瘫是一种慢性胃肠疾病,以胃排空延迟而无机械性梗阻为特征,可导致恶心、呕吐和腹痛等症状。尽管它对患者的生活质量有重大影响,但有效的管理仍然具有挑战性。目前的治疗方法,如促动力剂和止吐剂,可以缓解症状,但有局限性,需要探索新的方法。我们回顾了PubMed和Medline的最新文献,重点研究了胃轻瘫的病因、病理生理学和治疗,包括新型药物、内窥镜技术和生活方式的改变。新兴疗法,包括胃经口内窥镜肌切开术和胃促生长素激动剂,显示出改善患者预后的希望。在这篇综述中,我们研究了这些治疗进展,并讨论了它们在未来胃轻瘫治疗中的潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.10
自引率
0.00%
发文量
0
期刊最新文献
A multi-compound dietary supplement to improve the well-being of symptomatic uncomplicated diverticular disease. Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis. Efficacy of a probiotic-prebiotic mix on chronic constipation symptoms in the elderly: results of a pilot study. Automated glucose control systems in post-pancreatectomy diabetes: systematic review of clinical efficacy and nursing care implications. Markedly raised CA 19-9 levels in an asymptomatic patient: the role of Helicobacter pylori infection.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1